Researchposted Aug 06, 2020
Neuropsychiatric symptoms herald metabolic decline in Alzheimer’s disease
Kok Pin Ng, Tharick A. Pascoal, Sulantha Mathotaarachchi, Yiong Huak Chan, Lai Jiang, Joseph Therriault, Andrea L. Benedet, and 5 more authors
Under Review
at
Researchupdated Jul 21, 2020
Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders
Jie-Qiong Li, Yan-Lin Bi, Xue-Ning Shen, Hui-Fu Wang, Wei Xu, Chen-Chen Tan, Qiang Dong, and 3 more authors
Under Revision
at
Researchposted Jun 18, 2020
In Vivo Expression of Reprogramming Factor OCT4 Ameliorates Myelination Deficits and Induces Striatal Neuroprotection in Huntington’s Disease
Ji Hea Yu, Bae-Geun Nam, MinGi Kim, Jung Hwa Seo, Sung-Rae Cho
Under Review
at
Researchposted Apr 23, 2020
The C-terminal fragment of LRRK2 with the G2019S substitution increases the neurotoxicity of mutant A53T α-synuclein in dopaminergic neurons in vivo
Noémie Cresto, Camille Gardier, Marie-Claude Gaillard, Francesco Gubinelli, Pauline Roost, Daniela Molina, Charlène Joséphine, and 15 more authors
Under Revision
at